Archives
Tin Mesoporphyrin IX: Potent Heme Oxygenase Inhibitor for...
Tin Mesoporphyrin IX: A Potent Heme Oxygenase Inhibitor Empowering Metabolic and Viral Research
Introduction and Principle: The Role of Tin Mesoporphyrin IX (chloride) in Heme Oxygenase Pathway Modulation
The heme oxygenase (HO) pathway plays a central role in cellular redox regulation, heme degradation, and metabolic signaling. Tin Mesoporphyrin IX (chloride) is a potent and competitive inhibitor of heme oxygenase, with a Ki of 14 nM, making it one of the most selective agents for dissecting HO activity in experimental models. By inhibiting HO-mediated conversion of heme to biliverdin, iron, and carbon monoxide, this compound enables precise modulation of the heme oxygenase signaling pathway, impacting processes from bilirubin production to oxidative stress responses. Recent research underscores the significance of HO activity in metabolic disease, insulin resistance, metaflammation, and viral pathogenesis, positioning Tin Mesoporphyrin IX (chloride) as an indispensable molecular tool for both basic and translational scientists.
Experimental Workflow: Step-by-Step Integration of Tin Mesoporphyrin IX in Heme Oxygenase Activity Assays
Optimizing your experimental approach with Tin Mesoporphyrin IX (chloride) ensures maximum specificity in heme oxygenase activity assays and downstream analyses. Below is a detailed workflow for leveraging this compound in cellular and animal models:
1. Reagent Preparation and Storage
- Solubility: Dissolve Tin Mesoporphyrin IX (chloride) at up to 0.5 mg/ml in DMSO or 1 mg/ml in dimethyl formamide (DMF) for in vitro applications. For in vivo use, prepare fresh aliquots to minimize degradation, as solutions are recommended for short-term use only.
- Storage: Store the crystalline solid at -20°C, protected from light and moisture. Avoid repeated freeze-thaw cycles to preserve compound integrity.
2. In Vitro Heme Oxygenase Inhibition Assay
- Culture target cells (e.g., hepatocytes, immune cells) under standard conditions.
- Treat cells with serial dilutions of Tin Mesoporphyrin IX (chloride) (e.g., 1 nM to 10 µM) for 1–24 hours, depending on assay kinetics.
- Harvest cells and measure HO activity via spectrophotometric or HPLC-based biliverdin/bilirubin quantification.
- Validate inhibition by comparing to untreated and vehicle controls; expect near-complete HO inhibition at nanomolar concentrations (Ki = 14 nM).
3. In Vivo Application in Animal Models
- Administer Tin Mesoporphyrin IX (chloride) at 1 pmol/kg body weight via intraperitoneal or intravenous injection.
- Monitor HO activity in hepatic, renal, and splenic tissues over time (activity suppression can last up to 24–48 hours post-injection).
- Assess downstream biomarkers such as serum bilirubin (especially in neonatal hyperbilirubinemia models) and heme saturation of hepatic tryptophan pyrrolase.
4. Troubleshooting Common Issues in Assay Setup
- Low Inhibition: Confirm compound solubility and storage; degraded compound can cause reduced potency.
- Off-target Effects: Use appropriate controls and titrate concentrations conservatively to avoid cytotoxicity, especially above 10 µM.
- Batch Variability: Source from APExBIO to guarantee batch-to-batch consistency and purity.
Advanced Applications: Unraveling Metabolic and Viral Mechanisms Using Tin Mesoporphyrin IX
Beyond standard enzymatic assays, Tin Mesoporphyrin IX (chloride) is driving innovation in metabolic disease research, insulin resistance study, and metaflammation research by enabling targeted inhibition of heme catabolism. Its high affinity and selectivity make it ideal for dissecting the role of HO in:
- Metabolic Syndromes: Altered HO signaling is linked to obesity, diabetes, and NAFLD; Tin Mesoporphyrin IX (chloride) facilitates causal investigations by halting heme breakdown and modulating oxidative stress.
- Viral Pathogenesis: Recent studies, such as the Antiviral Research 2026 article, highlight how HO-1 upregulation alters hepatitis B virus (HBV) replication, assembly, and morphogenesis by modulating intracellular ROS levels. Tin Mesoporphyrin IX (chloride) enables reverse interrogation by efficiently blocking HO-1 activity, providing a robust platform to dissect HO-1’s antiviral and pro-viral roles at various stages of the viral life cycle.
- Inflammation and Redox Biology: The compound is invaluable for parsing out how HO-1-derived CO and biliverdin impact inflammatory and oxidative stress responses in immune and vascular cells.
For a comparative perspective, the article 'Tin Mesoporphyrin IX (chloride): Benchmark Potent Heme Ox...' complements these applications by providing detailed workflow integration, while 'Tin Mesoporphyrin IX (Chloride): Unlocking the Therapeutic...' extends these findings into translational contexts, examining viral and metabolic disease intersections. Additionally, 'Scenario-Driven Solutions with Tin Mesoporphyrin IX (chloride)...' offers practical troubleshooting and assay design strategies, underscoring the product’s flexibility across diverse research scenarios.
Comparative Advantages: Why Choose APExBIO’s Tin Mesoporphyrin IX?
- Benchmark Potency: With its 14 nM inhibition constant, Tin Mesoporphyrin IX (chloride) is among the most potent heme oxygenase inhibitors available, offering consistent and robust enzyme suppression in both in vitro and in vivo studies.
- Proven Reproducibility: APExBIO’s formulation is rigorously quality-controlled for purity and stability, minimizing experimental variability and maximizing data reproducibility, as highlighted in scenario-based guides.
- Versatile Solubility: The compound’s ability to dissolve in both DMSO and DMF enables flexible protocol integration across cell-based, biochemical, and animal model systems.
- Data-Driven Impact: In animal models, administration at 1 pmol/kg body weight not only suppresses HO activity for extended periods but also reliably reduces serum bilirubin by over 60% in neonatal hyperbilirubinemia models and increases hepatic heme saturation, supporting quantitative downstream analyses.
Troubleshooting and Optimization: Maximizing the Power of Tin Mesoporphyrin IX
Common Experimental Challenges and Solutions
- Compound Solubility: If precipitation occurs, gently warm the solution (not exceeding 37°C) and vortex thoroughly. Avoid aqueous buffers for stock solutions; dilute into culture or assay media immediately before use.
- Variable Inhibition: Ensure accurate dosing by calibrating pipettes and preparing fresh dilutions each time. For in vivo studies, filter-sterilize solutions and use within 1–2 hours of preparation.
- Cytotoxicity at High Concentrations: Begin with lower concentrations (1–100 nM) and include viability assays (e.g., MTT, CellTiter-Glo) to optimize dosing for your cell type and endpoint.
- Batch-to-Batch Reproducibility: Always record lot numbers and source exclusively from APExBIO to maintain experimental consistency.
- Interference with Downstream Readouts: When using spectrophotometric HO activity assays, confirm that Tin Mesoporphyrin IX (chloride) does not interfere with absorbance or fluorescence readings at the selected wavelengths.
Best Practices
- Validate HO inhibition using orthogonal readouts (e.g., Western blot for HO-1, mass spectrometry for biliverdin/bilirubin).
- Document storage and handling conditions in all protocols to support reproducibility.
- Cross-reference inhibition data with positive controls (e.g., Zn protoporphyrin) to benchmark Tin Mesoporphyrin IX’s performance.
Future Outlook: Harnessing HO Inhibition for Translational Breakthroughs
The landscape of heme oxygenase signaling pathway research is rapidly evolving, with Tin Mesoporphyrin IX (chloride) at the forefront. As highlighted in the recent HBV study, fine-tuned modulation of HO-1 can profoundly impact viral replication cycles, redox homeostasis, and immune responses. Future directions include:
- Development of Combination Therapies: Integrating HO inhibition with antiviral agents or metabolic modulators to enhance therapeutic efficacy in chronic HBV and metabolic disease contexts.
- Systems Biology Approaches: Leveraging omics platforms to map global changes in response to HO inhibition, revealing novel regulatory networks in metaflammation and insulin resistance.
- Expanding Model Systems: Use in organoid, co-culture, and patient-derived xenograft models to bridge bench findings with clinical translation.
- Clinical Translation: While no clinical trials of Tin Mesoporphyrin IX (chloride) are reported to date, its robust preclinical profile paves the way for future therapeutic exploration.
For researchers seeking a reliable, data-driven solution for inhibition of heme catabolism and pathway interrogation, APExBIO’s Tin Mesoporphyrin IX (chloride) sets the standard for performance and reproducibility. As new frontiers in metabolic and viral research continue to emerge, this compound is poised to remain an essential tool for discovery and innovation.